Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

Annals of Internal Medicine

Volumn 124, Issue 5, 1996, Pages 477-484

  Talar Williams, Cheryl ^a,b   Hijazi, Yasmine M ^a,c   Walther, McClellan M ^a,c   Linehan, W Marston ^a,c   Hallahan, Claire W ^a,b   Lubensky, Irina ^a,c   Kerr, Gail S ^a,d   Hoffman, Gary S ^a,e   Fauci, Anthony S ^a,b   Sneller, Michael C ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYCLOPHOSPHAMIDE; MITOMYCIN; PREDNISONE; THIOTEPA;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; URINE CYTOLOGY; WEGENER GRANULOMATOSIS;

EID: 13344277271     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-5-199603010-00003     Document Type: Article

References (24)

1. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years Ann Intern Med 1983;98:76-85
2. Fauci AS, Wolff SM. Wegener's granulomatosis: studies in eighteen patients and a review of the literature Medicine (Baltimore) 1973;52:535-61
3. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis an analysis of 158 patients. Ann Intern Med 1992;116:488-94
4. Pedersen-Bjergaard J, Ersboll J, Hansen VL, Sorensen BL, Christoffersen K, Hou-Jensen K, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma N Engl J Med. 1988;318:1028-32
5. Stillwell TJ, Benson RC Jr, DeRemee RA, McDonald TJ, Weiland LH. Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis. Arthritis Rheum 1988;31 465-70.
6. Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger Ta Jr. Malignancy following treatment of rheumatoid arthntis with cyclophosphamide. Long-term case-control follow-up study. Am J Med 1987;83:1-9
7. Plotz PH, Klippel JH, Decker JL, Grauman D, Wolff B, Brown BC, et al. Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis Ann Intern Med. 1979;91:221-3.
8. Weiss M. Urinary cytology of transitional cell neoplasms of the bladder In: Young RH, ed. Pathology of the Urinary Bladder New York. Churchill Livingstone; 1989:245-84
9. Forni A, Koss L, Geller W. Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man Cancer. 1964;17:1348-55
10. Coleman DV. The cytodiagnosis of human polyomavirus infection. Acta Cytol 1975;19:93-6.
11. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986;73:751-4
12. Cox DR. Regression models and life-tables. Journal of the Royal Statistical Society 1972;34:187-220.
13. Crowley J, Hu M. Covariance analysis of heart transplant survival data Journal of the American Statistical Association. 1977;72:27-36.
14. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations Journal of the American Statistical Association. 1958;53:457-81
15. Ries LA, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. Bethesda, MD: National Cancer Institute, 1994: NIH Pub No 94-2789
16. Fralser LH, Kanekal S, Kehrer JP, Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 1991;42:781-95
17. Cox PJ. Cyclophosphamide cystitis - identification of acrolein as the causative agent Biochem Pharmacol. 1979;28:2045-9.
18. Reza MJ, Dornfeld L, Goldberg LS, Bluestone R, Pearson CM. Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamide Arthritis Rheum. 1975;18:501-6.
19. Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone Arthritis Rheum. 1995;38:608-13
20. Gyde SN, Prior P, Allan RH. Stevens A, Jewell DP, Truelove SC, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres Gut 1988;29 206-17
21. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years Gut 1990;31 800-6
22. Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A. Colonoscopic surveillance in long- standing total ulcerative colitis - a 15-year follow-up study. Gastroenterology 1990;99:1021-31
23. Jewell DP. Ulcerative colitis In Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease Pathophysiology, Diagnosis, Management. 5th ed Philadelphia: WB Saunders, 1993:1305-30.
24. Korelitz B.I. Inflammatory bowel disease: cancer. In. Haubrich WS, Schaffner F, Berk JE, Bockus HL, eds Bockus Gastroenterology 5th ed. Philadelphia: WB Saunders, 1995 1364-81